Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2012, Article ID 741824, 9 pages
http://dx.doi.org/10.1155/2012/741824
Research Article

Portulaca oleracea Ameliorates Diabetic Vascular Inflammation and Endothelial Dysfunction in db/db Mice

1College of Oriental Medicine and Professional Graduate School of Oriental Medicine, Wonkwang University, Shinyong-dong, Iksan, Jeonbuk 570-749, Republic of Korea
2Hanbang Body-Fluid Research Center, Wonkwang University, Shinyong-dong, Iksan, Jeonbuk 570-749, Republic of Korea
3Korea Institute of Oriental Medicine, Jeonmin-dong, Yusung-gu, Daejeon 305-811, Republic of Korea

Received 5 July 2011; Revised 7 November 2011; Accepted 11 November 2011

Academic Editor: Jae Youl Cho

Copyright © 2012 An Sook Lee et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. Libby and J. Plutzky, “Diabetic macrovascular disease: the glucose paradox?” Circulation, vol. 106, no. 22, pp. 2760–2763, 2002. View at Publisher · View at Google Scholar · View at Scopus
  2. A. H. Mokdad, B. A. Bowman, E. S. Ford, F. Vinicor, J. S. Marks, and J. P. Koplan, “The continuing epidemics of obesity and diabetes in the United States,” Journal of the American Medical Association, vol. 286, no. 10, pp. 1195–1200, 2001. View at Google Scholar · View at Scopus
  3. M. Chakir and G. E. Plante, “Endothelial dysfunction in diabetes mellitus,” Prostaglandins Leukotrienes and Essential Fatty Acids, vol. 54, no. 1, pp. 45–51, 1996. View at Publisher · View at Google Scholar · View at Scopus
  4. A. K. Harris, J. R. Hutchinson, K. Sachidanandam et al., “Type 2 diabetes causes remodeling of cerebrovasculature via differential regulation of matrix metalloproteinases and collagen synthesis: role of endothelin-1,” Diabetes, vol. 54, no. 9, pp. 2638–2644, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. F. Z. Ammarguellat, P. O. Gannon, F. Amiri, and E. L. Schiffrin, “Fibrosis, matrix metalloproteinases, and inflammation in the heart of DOCA-salt hypertensive rats: role of ETa receptors,” Hypertension, vol. 39, no. 2, pp. 679–684, 2002. View at Publisher · View at Google Scholar · View at Scopus
  6. Z. S. Galis and J. J. Khatri, “Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly,” Circulation Research, vol. 90, no. 3, pp. 251–262, 2002. View at Google Scholar · View at Scopus
  7. R. Natarajan and J. L. Nadler, “Lipid inflammatory mediators in diabetic vascular disease,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 24, no. 9, pp. 1542–1548, 2004. View at Publisher · View at Google Scholar · View at Scopus
  8. J. H. Qiao, J. Tripathi, N. K. Mishra et al., “Role of macrophage colony-stimulating factor in atherosclerosis: studies of osteopetrotic mice,” American Journal of Pathology, vol. 150, no. 5, pp. 1687–1699, 1997. View at Google Scholar · View at Scopus
  9. W. A. Boisvert, R. Santiago, L. K. Curtiss, and R. A. Terkeltaub, “A leukocyte homologue of the IL-8 receptor CXCR-2 mediates the accumulation of macrophages in atherosclerotic lesions of LDL receptor- deficient mice,” Journal of Clinical Investigation, vol. 101, no. 2, pp. 353–363, 1998. View at Google Scholar · View at Scopus
  10. T. A. Springer, “Traffic signals on endothelium for lymphocyte recirculation and leukocyte emigration,” Annual Review of Physiology, vol. 57, pp. 827–872, 1995. View at Google Scholar · View at Scopus
  11. K. Ley and T. F. Tedder, “Leukocyte interactions with vascular endothelium: new insights into selectin-mediated attachment and rolling,” Journal of Immunology, vol. 155, no. 2, pp. 525–528, 1995. View at Google Scholar · View at Scopus
  12. Y. Huo, A. Hafezi-Moghadam, and K. Ley, “Role of vascular cell adhesion molecule-1 and fibronectin connecting segment-1 in monocyte rolling and adhesion on early atherosclerotic lesions,” Circulation Research, vol. 87, no. 2, pp. 153–159, 2000. View at Google Scholar · View at Scopus
  13. H. Chen, O. Charlat, L. A. Tartaglia et al., “Evidence that the diabetes gene encodes the leptin receptor: identification of a mutation in the leptin receptor gene in db/db mice,” Cell, vol. 84, no. 3, pp. 491–495, 1996. View at Publisher · View at Google Scholar · View at Scopus
  14. K. Kobayashi, T. M. Forte, S. Taniguchi, B. Y. Ishida, K. Oka, and L. Chan, “The db/db mouse, a model for diabetic dyslipidemia: molecular characterization and effects of western diet feeding,” Metabolism: Clinical and Experimental, vol. 49, no. 1, pp. 22–31, 2000. View at Google Scholar · View at Scopus
  15. S. Mohanapriya, P. Senthilkumar, S. Sivakumar, M. Dineshkumar, and C. V. Subbhuraam, “Effects of copper sulfate and copper nitrate in aquatic medium on the restoration potential and accumulation of copper in stem cuttings of the terrestrial medicinal plant, Portulaca oleracea linn.,” Environmental monitoring and assessment, vol. 121, no. 1-3, pp. 233–244, 2006. View at Google Scholar · View at Scopus
  16. A. N. Rasheed, F. U. Afifi, M. Shaedah, and M. O. Taha, “Investigation of the active constituents of Portulaca oleraceae L. (Portulacaceae) growing in Jordan,” Pakistan Journal of Pharmaceutical Sciences, vol. 17, pp. 37–45, 2004. View at Google Scholar
  17. X. J. Zhang, Y. B. Ji, Z. Y. Qu, J. C. Xia, and L. Wang, “Experimental studies on antibiotic functions of Portulaca oleracea L. in vitro,” Chinese Journal of Microecology, vol. 14, pp. 277–280, 2002. View at Google Scholar
  18. K. Chan, M. W. Islam, M. Kamil et al., “The analgesic and anti-inflammatory effects of Portulaca oleracea L. subsp. sativa (Haw.) Celak,” Journal of Ethnopharmacology, vol. 73, no. 3, pp. 445–451, 2000. View at Publisher · View at Google Scholar · View at Scopus
  19. O. Parry, J. A. Marks, and F. K. Okwuasaba, “The skeletal muscle relaxant action of Portulaca oleracea: role of potassium ions,” Journal of Ethnopharmacology, vol. 40, no. 3, pp. 187–194, 1993. View at Publisher · View at Google Scholar · View at Scopus
  20. A. N. Rashed, F. U. Afifi, and A. M. Disi, “Simple evaluation of the wound healing activity of a crude extract of Portulaca oleracea L. (growing in Jordan) in Mus musculus JVI-1,” Journal of Ethnopharmacology, vol. 88, no. 2-3, pp. 131–136, 2003. View at Publisher · View at Google Scholar · View at Scopus
  21. N. E. Awad, “Lipid content and antimicrobial activity of phenolic constituents of cultivated Portulaca oleracea L.,” Bulletin of Faculty of Pharmacy, vol. 32, pp. 137–142, 1994. View at Google Scholar
  22. N. Sakai, K. Inada, M. Okamoto, Y. Shizuri, and Y. Fukuyama, “Portuloside A, a monoterpene glucoside, from Portulaca oleracea,” Phytochemistry, vol. 42, no. 6, pp. 1625–1628, 1996. View at Publisher · View at Google Scholar · View at Scopus
  23. L. Liu, P. Howe, Y. F. Zhou, Z. Q. Xu, C. Hocart, and R. Zhang, “Fatty acids and β-carotene in Australian purslane (Portulaca oleracea) varieties,” Journal of Chromatography A, vol. 893, no. 1, pp. 207–213, 2000. View at Publisher · View at Google Scholar · View at Scopus
  24. D. G. Kang, H. Oh, D. K. Cho, E. K. Kwon, J. H. Han, and H. S. Lee, “Effects of bulb of Fritillaria ussuriensis maxim. on angiotensin converting enzyme and vascular release of NO/cGMP in rats,” Journal of Ethnopharmacology, vol. 81, no. 1, pp. 49–55, 2002. View at Publisher · View at Google Scholar · View at Scopus
  25. P. M. Ridker, N. Rifai, L. Rose, J. E. Buring, and N. R. Cook, “Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events,” New England Journal of Medicine, vol. 347, no. 20, pp. 1557–1565, 2002. View at Publisher · View at Google Scholar · View at Scopus
  26. C. G. Schalkwijk and C. D. A. Stehouwer, “Vascular complications in diabetes mellitus: the role of endothelial dysfunction,” Clinical Science, vol. 109, no. 2, pp. 143–159, 2005. View at Publisher · View at Google Scholar · View at Scopus
  27. A. E. Caballero, “Endothelial dysfunction in obesity and insulin resistance: a road to diabetes and heart disease,” Obesity Research, vol. 11, no. 11, pp. 1278–1289, 2003. View at Google Scholar · View at Scopus
  28. C. D. A. Stehouwer, M. A. Gall, J. W. R. Twisk, E. Knudsen, J. J. Emeis, and H. H. Parving, “Increased urinary albumin excretion, endothelial dysfunction, and chronic low-grade inflammation in type 2 diabetes: progressive, interrelated, and independently associated with risk of death,” Diabetes, vol. 51, no. 4, pp. 1157–1165, 2002. View at Google Scholar · View at Scopus
  29. D. H. Endemann and E. L. Schiffrin, “Nitric oxide, oxidative excess, and vascular complications of diabetes mellitus,” Current Hypertension Reports, vol. 6, no. 2, pp. 85–89, 2004. View at Google Scholar · View at Scopus
  30. N. F. Voelkel and R. M. Tuder, “Hypoxia-induced pulmonary vascular remodeling: a model for what human disease?” Journal of Clinical Investigation, vol. 106, no. 6, pp. 733–738, 2000. View at Google Scholar · View at Scopus
  31. T. Miike, K. Kunishiro, M. Kanda, S. Azukizawa, K. Kurahashi, and H. Shirahase, “Impairment of endothelium-dependent ACh-induced relaxation in aorta of diabetic db/db mice-possible dysfunction of receptor and/or receptor-G protein coupling,” Naunyn-Schmiedeberg's Archives of Pharmacology, vol. 377, no. 4–6, pp. 401–410, 2008. View at Publisher · View at Google Scholar · View at Scopus
  32. Z. Guo, W. Su, S. Allen et al., “COX-2 Up-regulation and vascular smooth muscle contractile hyperreactivity in spontaneous diabetic db/db mice,” Cardiovascular Research, vol. 67, no. 4, pp. 723–735, 2005. View at Publisher · View at Google Scholar · View at Scopus
  33. M. J. Orland and M. A. Permutt, “Quantitative analysis of pancreatic proinsulin mRNA in genetically diabetic (db/db) mice,” Diabetes, vol. 36, no. 3, pp. 341–347, 1987. View at Google Scholar · View at Scopus
  34. R. P. Robertson, H. J. Zhang, K. L. Pyzdrowski, and T. F. Walseth, “Preservation of insulin mRNA levels and insulin secretion in HIT cells by avoidance of chronic exposure to high glucose concentrations,” Journal of Clinical Investigation, vol. 90, no. 2, pp. 320–325, 1992. View at Google Scholar · View at Scopus
  35. A. Sharma, M. Vijayakumar, C. V. Rao, M. K. Unnikrishnan, and G. D. Reddy, “Action of Portulaca oleracea against streptozotocin-induced oxidative stress in experimental diabetic rats,” Journal of Complementary and Integrative Medicine, vol. 6, no. 1, article no. 1, 2009. View at Publisher · View at Google Scholar · View at Scopus
  36. J. Behravan, F. Mosafa, N. Soudmand, E. Taghiabadi, B. M. Razavi, and G. Karimi, “Protective effects of aqueous and ethanolic extracts of Portulaca oleracea L. Aerial Parts on H2O2-induced DNA damage in lymphocytes by comet assay,” Journal of Acupuncture and Meridian Studies, vol. 4, no. 3, pp. 193–197, 2011. View at Publisher · View at Google Scholar